Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20117004rdf:typepubmed:Citationlld:pubmed
pubmed-article:20117004lifeskim:mentionsumls-concept:C0694890lld:lifeskim
pubmed-article:20117004lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:20117004lifeskim:mentionsumls-concept:C0038477lld:lifeskim
pubmed-article:20117004lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:20117004lifeskim:mentionsumls-concept:C0543431lld:lifeskim
pubmed-article:20117004lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:20117004lifeskim:mentionsumls-concept:C0243077lld:lifeskim
pubmed-article:20117004lifeskim:mentionsumls-concept:C1136847lld:lifeskim
pubmed-article:20117004pubmed:issue4lld:pubmed
pubmed-article:20117004pubmed:dateCreated2010-2-17lld:pubmed
pubmed-article:20117004pubmed:abstractTextThe synthesis, structure-activity relationships (SAR) and structural data of a series of indolin-2-one inhibitors of RET tyrosine kinase are described. These compounds were designed to explore the available space around the indolinone scaffold within RET active site. Several substitutions at different positions were tested and biochemical data were used to draw a molecular model of steric and electrostatic interactions, which can be applied to design more potent and selective RET inhibitors. The crystal structures of RET kinase domain in complex with three inhibitors were solved. All three compounds bound in the ATP pocket and formed two hydrogen bonds with the kinase hinge region. Crystallographic analysis confirmed predictions from molecular modelling and helped refine SAR results. These data provide important information for the development of indolinone inhibitors for the treatment of RET-driven cancers.lld:pubmed
pubmed-article:20117004pubmed:languageenglld:pubmed
pubmed-article:20117004pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20117004pubmed:citationSubsetIMlld:pubmed
pubmed-article:20117004pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20117004pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20117004pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20117004pubmed:statusMEDLINElld:pubmed
pubmed-article:20117004pubmed:monthFeblld:pubmed
pubmed-article:20117004pubmed:issn1464-3391lld:pubmed
pubmed-article:20117004pubmed:authorpubmed-author:Gambacorti-Pa...lld:pubmed
pubmed-article:20117004pubmed:authorpubmed-author:ZambonAlfonso...lld:pubmed
pubmed-article:20117004pubmed:authorpubmed-author:ScapozzaLeona...lld:pubmed
pubmed-article:20117004pubmed:authorpubmed-author:Murray-RustJu...lld:pubmed
pubmed-article:20117004pubmed:authorpubmed-author:McDonaldNeil...lld:pubmed
pubmed-article:20117004pubmed:authorpubmed-author:LucchiniVitto...lld:pubmed
pubmed-article:20117004pubmed:authorpubmed-author:RostagnoRober...lld:pubmed
pubmed-article:20117004pubmed:authorpubmed-author:KjaerSvendSlld:pubmed
pubmed-article:20117004pubmed:authorpubmed-author:MologniLucaLlld:pubmed
pubmed-article:20117004pubmed:authorpubmed-author:KnowlesPhilli...lld:pubmed
pubmed-article:20117004pubmed:authorpubmed-author:BrussoloStefa...lld:pubmed
pubmed-article:20117004pubmed:authorpubmed-author:RossoEnricoElld:pubmed
pubmed-article:20117004pubmed:copyrightInfoCopyright 2010 Elsevier Ltd. All rights reserved.lld:pubmed
pubmed-article:20117004pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20117004pubmed:day15lld:pubmed
pubmed-article:20117004pubmed:volume18lld:pubmed
pubmed-article:20117004pubmed:ownerNLMlld:pubmed
pubmed-article:20117004pubmed:authorsCompleteYlld:pubmed
pubmed-article:20117004pubmed:pagination1482-96lld:pubmed
pubmed-article:20117004pubmed:meshHeadingpubmed-meshheading:20117004...lld:pubmed
pubmed-article:20117004pubmed:meshHeadingpubmed-meshheading:20117004...lld:pubmed
pubmed-article:20117004pubmed:meshHeadingpubmed-meshheading:20117004...lld:pubmed
pubmed-article:20117004pubmed:meshHeadingpubmed-meshheading:20117004...lld:pubmed
pubmed-article:20117004pubmed:meshHeadingpubmed-meshheading:20117004...lld:pubmed
pubmed-article:20117004pubmed:meshHeadingpubmed-meshheading:20117004...lld:pubmed
pubmed-article:20117004pubmed:meshHeadingpubmed-meshheading:20117004...lld:pubmed
pubmed-article:20117004pubmed:meshHeadingpubmed-meshheading:20117004...lld:pubmed
pubmed-article:20117004pubmed:meshHeadingpubmed-meshheading:20117004...lld:pubmed
pubmed-article:20117004pubmed:year2010lld:pubmed
pubmed-article:20117004pubmed:articleTitleSynthesis, structure-activity relationship and crystallographic studies of 3-substituted indolin-2-one RET inhibitors.lld:pubmed
pubmed-article:20117004pubmed:affiliationDepartment of Clinical Medicine and Prevention, University of Milano-Bicocca, Monza, Italy. luca.mologni@unimib.itlld:pubmed
pubmed-article:20117004pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20117004pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:20117004lld:chembl